Prolonged SARS-CoV-2 replication in an immunocompromised patient
Ji Hoong Baang; Christopher Smith; Carmen Mirabelli; Andrew L. Valesano; David M. Manthei; Michael Bachman; Christiane E. Wobus; Michael Adams; Laraine Washer; Emily T. Martin; Adam S. Lauring.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20196899
We describe a case of chronic COVID-19 in a patient with lymphoma and associated B-cell immunodeficiency. Viral cultures and sequence analysis demonstrate ongoing replication of infectious SARS-CoV-2 virus for at least 119 days. The patient had three admissions related to COVID-19 over a four-month period and was treated twice with remdesivir and convalescent plasma with resolution of symptoms. The lack of seroconversion and prolonged course illustrate the importance of humoral immunity in resolving SARS-CoV-2 infection. This case highlights challenges in managing immunocompromised hosts, who may act as persistent shedders and sources of transmission.
Texto completo
Documentos relacionados